Reduction of serum TFF3 levels and tumour expression of TFF3 by AMPC was accompanied by decreased expression of the proliferative marker Ki67 in both the doxorubicin sensitive and resistant ER+MC xenografts (Figure 7e,f,h,i). This evidence concerns the gene MKI67 and neoplasm.